Showing results (301-310 of 338) with videos related to

Sort By:
Pageof 34
Science (New York, N.Y.)|June 29, 2019
Generation of extreme-ultraviolet beams with time-varying orbital angular momentumLaura Rego, Kevin M Dorney, Nathan J Brooks, et al.
JACC. Basic to Translational Science|December 14, 2021
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized TrialThorsten M Leucker, William O Osburn, Paula Reventun, et al.
Journal of the American College of Cardiology|February 1, 1997
Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) StudyR Sicari, E Picano, P Landi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 11, 2017
Association of QT-Prolonging Medication Use in CKD with Electrocardiographic ManifestationsSoren Snitker, Rebecca M Doerfler, Elsayed Z Soliman, et al.
Molecular Cell|June 2, 2007
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosisTsung-Cheng Chang, Erik A Wentzel, Oliver A Kent, et al.
The Journal of Experimental Medicine|February 20, 2008
Glutamate mediates platelet activation through the AMPA receptorCraig N Morrell, Henry Sun, Masahiro Ikeda, et al.
Circulation Research|November 26, 2025
Functional Genomics Link REST to Endothelial Plasticity and AtherosclerosisMaria Viskadourou, Sharjeel Chaudhry, Arianna Scalco, et al.
Environmental Research|February 8, 2017
Associations between ambient wood smoke and other particulate pollutants and biomarkers of systemic inflammation, coagulation and thrombosis in cardiac patientsDaniel P Croft, Scott J Cameron, Craig N Morrell, et al.
Circulation|September 16, 1998
Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic studyE Picano, R Sicari, P Landi, et al.
Molecular Therapy. Methods & Clinical Development|November 16, 2022
LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept studyAlexandria M Doerfler, So Hyun Park, Julia M Assini, et al.
Pageof 34